Review



cell line caco2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC cell line caco2
    Cell Line Caco2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 15122 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pm42268947-239-1-8
    Average 99 stars, based on 15122 article reviews
    cell line caco2 - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5′-Terminal Oligopyrimidine Motif-Containing mRNA
    Article Snippet: Huh-7 cells (human hepatocarcinoma; JCRB), Vero cells (African green monkey kidney fibroblast; ATCC) RD cells (Human Rhabdomyosarcoma; ATCC) and SH-SY5Y (human neuroblastoma; ATCC) were cultured in DMEM medium (Gibco) with 4.5 g/L glucose, 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) penicillin/streptomycin (P/S) at 37 °C in 5% CO 2 . .. Caco2 cells (human colon adenocarcinoma; ATCC) were cultured in DMEM medium, supplemented with GlutaMAX, 10% FBS and 1% P/S at 37 °C in 5% CO 2 . .. BHK-21 cells (baby hamster kidney fibroblast; ATCC) in RPMI 1640 medium (Gibco) supplemented with 10% FBS and 1% P/S at 37 °C in 5% CO 2 .

    Article Title: Luteolin Inhibits Invasion of Listeria monocytogenes by Interacting with SortaseA and InternalinB.
    Article Snippet: .. Human colorectal adenocarcinoma cells, Caco2 cells, were obtained from American Type Culture Collection (ATCC); cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Sangon Biotech, Shanghai, China) with 10% fetal bovine serum (FBS, Sangon Biotech, Shanghai, China). .. LM ATCC BAA-679 strain was purchased from ATCC (Manassas, VA, USA), the bacteria was cultured in Brain Heart Infusion (BHI, Hopebiol, Qingdao, China) Broth without or with agar.

    Article Title: Parabacteroides distasonis regulates PPARɑ to alleviate colchicine-induced colonic injury through p-cresol sulfate.
    Article Snippet: Colchicine has been extensively utilized for treating gouty arthritis over many years, yet its dose-limiting gastrointestinal toxicity remains a significant clinical challenge.. While diarrhoea and nausea are well recognised, the extent of colchicine-induced occult colonic injury-including its impact on the gut microbiota and mucosal homeostasis-is poorly defined.. This study investigates colchicine-induced colonic injury (e.g., oxidative stress, mitochondrial dysfunction) in vivo and in vitro and also the imbalance of gut microbiota composition in mice.

    Modification:

    Article Title: Luteolin Inhibits Invasion of Listeria monocytogenes by Interacting with SortaseA and InternalinB.
    Article Snippet: .. Human colorectal adenocarcinoma cells, Caco2 cells, were obtained from American Type Culture Collection (ATCC); cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Sangon Biotech, Shanghai, China) with 10% fetal bovine serum (FBS, Sangon Biotech, Shanghai, China). .. LM ATCC BAA-679 strain was purchased from ATCC (Manassas, VA, USA), the bacteria was cultured in Brain Heart Infusion (BHI, Hopebiol, Qingdao, China) Broth without or with agar.



    Similar Products

    99
    ATCC cell line caco2
    Cell Line Caco2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pm42268947-239-1-8
    Average 99 stars, based on 1 article reviews
    cell line caco2 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC caco2 cells
    Caco2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pm42235908-84-0-5
    Average 99 stars, based on 1 article reviews
    caco2 cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC caco2 human colorectal adenocarcinoma cells
    Cytotoxicity of epoxidized linoleic acid in <t>Caco2</t> cells. Cells were incubated with 9(10)-EpOME or 12(13)-EpOME for 2, 4 and 24 h (white, grey and black bars), and cell proliferation over 24 h (A) as well as cytotoxicity by LDH release assay (B), neutral red uptake assay (C) and AlamarBlue assay (D) were assessed. All data are shown as mean +SD (n = 3-6) (Two-way ANOVA followed by Dunnett's multiple comparisons test, ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001, compared to control), with Ctr: vehicle control for LDH release assay and medium control for proliferation assay, neutral red assay and AlamarBlue assay, and Pos: positive control.
    Caco2 Human Colorectal Adenocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pmc13139969-29-0-9
    Average 99 stars, based on 1 article reviews
    caco2 human colorectal adenocarcinoma cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC epithelial cell line caco2
    Granzyme‐B is the key cell death mediator in enterocyte‐induced cell death and is only secreted by aberrant intra‐epithelial T‐lymphocyte (IEL) in the presence of enterocytes. (a) Cytoplasmic localisation of granzyme‐B granules in refractory celiac disease type II (RCDII) cells P2 using immunofluorescence (red, granzyme‐B; blue, DAPI nucleus staining, 100× magnification). (b) Expression of degranulation marker CD107a on RCDII cell lines P1 and P2 in the absence and presence of epithelial <t>Caco2</t> cells after 4 h of incubation. (c) CD107a expression on aberrant IEL of a duodenal biopsy from a representative RCDII patient with villous atrophy after 4 h of incubation; left panel, isotype‐matched control. (d) Granzyme‐B secretion by RCDII cell lines in the absence and presence of enterocyte cell line Caco2 after 6 h of incubation. (e) RCDII cell lines P1 and P2 induce killing of epithelial Caco2 cells. The control cell line SUDHL4 showed no cytotoxicity against the Caco2 cells. (f) Enterocyte cell death by RCDII cells incubated with increasing concentrations of degranulation blocker hydroxychloroquine sulphate (HCQ). (g) Killing of intestinal Caco2 cells by RCDII cells in the presence of increasing concentrations of the granzyme‐B inhibitor Z‐AAD‐CH2Cl. For cell death assays, cytotoxicity was measured after 16 h of co‐incubation at an effector:target ratio 2:1. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results are shown as mean + sem.
    Epithelial Cell Line Caco2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pmc13175919-189-2-10
    Average 99 stars, based on 1 article reviews
    epithelial cell line caco2 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC caco2 cells human caco2 crc cell lines
    Granzyme‐B is the key cell death mediator in enterocyte‐induced cell death and is only secreted by aberrant intra‐epithelial T‐lymphocyte (IEL) in the presence of enterocytes. (a) Cytoplasmic localisation of granzyme‐B granules in refractory celiac disease type II (RCDII) cells P2 using immunofluorescence (red, granzyme‐B; blue, DAPI nucleus staining, 100× magnification). (b) Expression of degranulation marker CD107a on RCDII cell lines P1 and P2 in the absence and presence of epithelial <t>Caco2</t> cells after 4 h of incubation. (c) CD107a expression on aberrant IEL of a duodenal biopsy from a representative RCDII patient with villous atrophy after 4 h of incubation; left panel, isotype‐matched control. (d) Granzyme‐B secretion by RCDII cell lines in the absence and presence of enterocyte cell line Caco2 after 6 h of incubation. (e) RCDII cell lines P1 and P2 induce killing of epithelial Caco2 cells. The control cell line SUDHL4 showed no cytotoxicity against the Caco2 cells. (f) Enterocyte cell death by RCDII cells incubated with increasing concentrations of degranulation blocker hydroxychloroquine sulphate (HCQ). (g) Killing of intestinal Caco2 cells by RCDII cells in the presence of increasing concentrations of the granzyme‐B inhibitor Z‐AAD‐CH2Cl. For cell death assays, cytotoxicity was measured after 16 h of co‐incubation at an effector:target ratio 2:1. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results are shown as mean + sem.
    Caco2 Cells Human Caco2 Crc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pm42091596-284-2-12
    Average 99 stars, based on 1 article reviews
    caco2 cells human caco2 crc cell lines - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC human colorectal adenocarcinoma caco2 tc7 cells
    Granzyme‐B is the key cell death mediator in enterocyte‐induced cell death and is only secreted by aberrant intra‐epithelial T‐lymphocyte (IEL) in the presence of enterocytes. (a) Cytoplasmic localisation of granzyme‐B granules in refractory celiac disease type II (RCDII) cells P2 using immunofluorescence (red, granzyme‐B; blue, DAPI nucleus staining, 100× magnification). (b) Expression of degranulation marker CD107a on RCDII cell lines P1 and P2 in the absence and presence of epithelial <t>Caco2</t> cells after 4 h of incubation. (c) CD107a expression on aberrant IEL of a duodenal biopsy from a representative RCDII patient with villous atrophy after 4 h of incubation; left panel, isotype‐matched control. (d) Granzyme‐B secretion by RCDII cell lines in the absence and presence of enterocyte cell line Caco2 after 6 h of incubation. (e) RCDII cell lines P1 and P2 induce killing of epithelial Caco2 cells. The control cell line SUDHL4 showed no cytotoxicity against the Caco2 cells. (f) Enterocyte cell death by RCDII cells incubated with increasing concentrations of degranulation blocker hydroxychloroquine sulphate (HCQ). (g) Killing of intestinal Caco2 cells by RCDII cells in the presence of increasing concentrations of the granzyme‐B inhibitor Z‐AAD‐CH2Cl. For cell death assays, cytotoxicity was measured after 16 h of co‐incubation at an effector:target ratio 2:1. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results are shown as mean + sem.
    Human Colorectal Adenocarcinoma Caco2 Tc7 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pmc13185562-266-0-5
    Average 99 stars, based on 1 article reviews
    human colorectal adenocarcinoma caco2 tc7 cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC cell lines caco2
    Granzyme‐B is the key cell death mediator in enterocyte‐induced cell death and is only secreted by aberrant intra‐epithelial T‐lymphocyte (IEL) in the presence of enterocytes. (a) Cytoplasmic localisation of granzyme‐B granules in refractory celiac disease type II (RCDII) cells P2 using immunofluorescence (red, granzyme‐B; blue, DAPI nucleus staining, 100× magnification). (b) Expression of degranulation marker CD107a on RCDII cell lines P1 and P2 in the absence and presence of epithelial <t>Caco2</t> cells after 4 h of incubation. (c) CD107a expression on aberrant IEL of a duodenal biopsy from a representative RCDII patient with villous atrophy after 4 h of incubation; left panel, isotype‐matched control. (d) Granzyme‐B secretion by RCDII cell lines in the absence and presence of enterocyte cell line Caco2 after 6 h of incubation. (e) RCDII cell lines P1 and P2 induce killing of epithelial Caco2 cells. The control cell line SUDHL4 showed no cytotoxicity against the Caco2 cells. (f) Enterocyte cell death by RCDII cells incubated with increasing concentrations of degranulation blocker hydroxychloroquine sulphate (HCQ). (g) Killing of intestinal Caco2 cells by RCDII cells in the presence of increasing concentrations of the granzyme‐B inhibitor Z‐AAD‐CH2Cl. For cell death assays, cytotoxicity was measured after 16 h of co‐incubation at an effector:target ratio 2:1. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results are shown as mean + sem.
    Cell Lines Caco2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pm41951040-55-3-18
    Average 99 stars, based on 1 article reviews
    cell lines caco2 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    98
    Beijing Solarbio Science caco2 cells
    Granzyme‐B is the key cell death mediator in enterocyte‐induced cell death and is only secreted by aberrant intra‐epithelial T‐lymphocyte (IEL) in the presence of enterocytes. (a) Cytoplasmic localisation of granzyme‐B granules in refractory celiac disease type II (RCDII) cells P2 using immunofluorescence (red, granzyme‐B; blue, DAPI nucleus staining, 100× magnification). (b) Expression of degranulation marker CD107a on RCDII cell lines P1 and P2 in the absence and presence of epithelial <t>Caco2</t> cells after 4 h of incubation. (c) CD107a expression on aberrant IEL of a duodenal biopsy from a representative RCDII patient with villous atrophy after 4 h of incubation; left panel, isotype‐matched control. (d) Granzyme‐B secretion by RCDII cell lines in the absence and presence of enterocyte cell line Caco2 after 6 h of incubation. (e) RCDII cell lines P1 and P2 induce killing of epithelial Caco2 cells. The control cell line SUDHL4 showed no cytotoxicity against the Caco2 cells. (f) Enterocyte cell death by RCDII cells incubated with increasing concentrations of degranulation blocker hydroxychloroquine sulphate (HCQ). (g) Killing of intestinal Caco2 cells by RCDII cells in the presence of increasing concentrations of the granzyme‐B inhibitor Z‐AAD‐CH2Cl. For cell death assays, cytotoxicity was measured after 16 h of co‐incubation at an effector:target ratio 2:1. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results are shown as mean + sem.
    Caco2 Cells, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/RPMI+1640/10__1016_slash_j__jff__2026__107256-39-5-15
    Average 98 stars, based on 1 article reviews
    caco2 cells - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    99
    ATCC colorectal adenocarcinoma cells caco2
    Granzyme‐B is the key cell death mediator in enterocyte‐induced cell death and is only secreted by aberrant intra‐epithelial T‐lymphocyte (IEL) in the presence of enterocytes. (a) Cytoplasmic localisation of granzyme‐B granules in refractory celiac disease type II (RCDII) cells P2 using immunofluorescence (red, granzyme‐B; blue, DAPI nucleus staining, 100× magnification). (b) Expression of degranulation marker CD107a on RCDII cell lines P1 and P2 in the absence and presence of epithelial <t>Caco2</t> cells after 4 h of incubation. (c) CD107a expression on aberrant IEL of a duodenal biopsy from a representative RCDII patient with villous atrophy after 4 h of incubation; left panel, isotype‐matched control. (d) Granzyme‐B secretion by RCDII cell lines in the absence and presence of enterocyte cell line Caco2 after 6 h of incubation. (e) RCDII cell lines P1 and P2 induce killing of epithelial Caco2 cells. The control cell line SUDHL4 showed no cytotoxicity against the Caco2 cells. (f) Enterocyte cell death by RCDII cells incubated with increasing concentrations of degranulation blocker hydroxychloroquine sulphate (HCQ). (g) Killing of intestinal Caco2 cells by RCDII cells in the presence of increasing concentrations of the granzyme‐B inhibitor Z‐AAD‐CH2Cl. For cell death assays, cytotoxicity was measured after 16 h of co‐incubation at an effector:target ratio 2:1. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results are shown as mean + sem.
    Colorectal Adenocarcinoma Cells Caco2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/caco2+cells/Caco-2/pm41812506-75-8-1
    Average 99 stars, based on 1 article reviews
    colorectal adenocarcinoma cells caco2 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    Cytotoxicity of epoxidized linoleic acid in Caco2 cells. Cells were incubated with 9(10)-EpOME or 12(13)-EpOME for 2, 4 and 24 h (white, grey and black bars), and cell proliferation over 24 h (A) as well as cytotoxicity by LDH release assay (B), neutral red uptake assay (C) and AlamarBlue assay (D) were assessed. All data are shown as mean +SD (n = 3-6) (Two-way ANOVA followed by Dunnett's multiple comparisons test, ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001, compared to control), with Ctr: vehicle control for LDH release assay and medium control for proliferation assay, neutral red assay and AlamarBlue assay, and Pos: positive control.

    Journal: Biochemistry and Biophysics Reports

    Article Title: Low cytotoxicity of linoleic acid-derived epoxy-fatty acids in liver and colon cell lines

    doi: 10.1016/j.bbrep.2026.102607

    Figure Lengend Snippet: Cytotoxicity of epoxidized linoleic acid in Caco2 cells. Cells were incubated with 9(10)-EpOME or 12(13)-EpOME for 2, 4 and 24 h (white, grey and black bars), and cell proliferation over 24 h (A) as well as cytotoxicity by LDH release assay (B), neutral red uptake assay (C) and AlamarBlue assay (D) were assessed. All data are shown as mean +SD (n = 3-6) (Two-way ANOVA followed by Dunnett's multiple comparisons test, ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001, compared to control), with Ctr: vehicle control for LDH release assay and medium control for proliferation assay, neutral red assay and AlamarBlue assay, and Pos: positive control.

    Article Snippet: Caco2 human colorectal adenocarcinoma cells were purchased from the American Type Culture Collection (ATCC, local distributor LGC Standards GmbH, Wesel, Germany).

    Techniques: Incubation, Lactate Dehydrogenase Assay, Alamar Blue Assay, Control, Proliferation Assay, Neutral Red Assay, Positive Control

    Granzyme‐B is the key cell death mediator in enterocyte‐induced cell death and is only secreted by aberrant intra‐epithelial T‐lymphocyte (IEL) in the presence of enterocytes. (a) Cytoplasmic localisation of granzyme‐B granules in refractory celiac disease type II (RCDII) cells P2 using immunofluorescence (red, granzyme‐B; blue, DAPI nucleus staining, 100× magnification). (b) Expression of degranulation marker CD107a on RCDII cell lines P1 and P2 in the absence and presence of epithelial Caco2 cells after 4 h of incubation. (c) CD107a expression on aberrant IEL of a duodenal biopsy from a representative RCDII patient with villous atrophy after 4 h of incubation; left panel, isotype‐matched control. (d) Granzyme‐B secretion by RCDII cell lines in the absence and presence of enterocyte cell line Caco2 after 6 h of incubation. (e) RCDII cell lines P1 and P2 induce killing of epithelial Caco2 cells. The control cell line SUDHL4 showed no cytotoxicity against the Caco2 cells. (f) Enterocyte cell death by RCDII cells incubated with increasing concentrations of degranulation blocker hydroxychloroquine sulphate (HCQ). (g) Killing of intestinal Caco2 cells by RCDII cells in the presence of increasing concentrations of the granzyme‐B inhibitor Z‐AAD‐CH2Cl. For cell death assays, cytotoxicity was measured after 16 h of co‐incubation at an effector:target ratio 2:1. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results are shown as mean + sem.

    Journal: Clinical & Translational Immunology

    Article Title: Aberrant intra‐epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103 ‐β7‐receptor‐mediated granzyme‐B degranulation which can be restored by etrolizumab

    doi: 10.1002/cti2.70099

    Figure Lengend Snippet: Granzyme‐B is the key cell death mediator in enterocyte‐induced cell death and is only secreted by aberrant intra‐epithelial T‐lymphocyte (IEL) in the presence of enterocytes. (a) Cytoplasmic localisation of granzyme‐B granules in refractory celiac disease type II (RCDII) cells P2 using immunofluorescence (red, granzyme‐B; blue, DAPI nucleus staining, 100× magnification). (b) Expression of degranulation marker CD107a on RCDII cell lines P1 and P2 in the absence and presence of epithelial Caco2 cells after 4 h of incubation. (c) CD107a expression on aberrant IEL of a duodenal biopsy from a representative RCDII patient with villous atrophy after 4 h of incubation; left panel, isotype‐matched control. (d) Granzyme‐B secretion by RCDII cell lines in the absence and presence of enterocyte cell line Caco2 after 6 h of incubation. (e) RCDII cell lines P1 and P2 induce killing of epithelial Caco2 cells. The control cell line SUDHL4 showed no cytotoxicity against the Caco2 cells. (f) Enterocyte cell death by RCDII cells incubated with increasing concentrations of degranulation blocker hydroxychloroquine sulphate (HCQ). (g) Killing of intestinal Caco2 cells by RCDII cells in the presence of increasing concentrations of the granzyme‐B inhibitor Z‐AAD‐CH2Cl. For cell death assays, cytotoxicity was measured after 16 h of co‐incubation at an effector:target ratio 2:1. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results are shown as mean + sem.

    Article Snippet: The intestinal epithelial cell line Caco2 was obtained from the American Type Culture Collection (ATCC) and cultured with DMEM medium (BioWhittaker) containing 10% FBS (GE Healthcare Life Sciences) and 100 IU penicillin/100 μg/mL streptomycin (1% P/S) at 37°C.

    Techniques: Immunofluorescence, Staining, Expressing, Marker, Incubation, Control

    Aberrant intra‐epithelial T‐lymphocyte (IEL) demonstrate upregulated expression of CD103 and require cell–cell binding to induce enterocyte killing. (a) Refractory celiac disease type II (RCDII) cell‐induced cytotoxicity of Caco2 cells in the presence of a transwell system. Cell death was measured after 16 h of co‐incubation at an effector:target ratio 2:1. (b) Degranulation by RCDII cells in the presence of a transwell system. CD107a expression was measured after 4 h of co‐incubation with Caco2 cells at an effector:target ratio 2:1. (c) NKG2D expression on aberrant IEL of RCDII patients and patients with celiac disease (CD) on gluten‐free diet (GFD), using flow cytometry analysis. Activated CD8+ T cells served as positive control. (d) Representative histograms of NKG2D expression on RCDII cell lines P1 and P2 using flow cytometry; grey shaded peak, isotype‐matched control. (e) Killing of epithelial cells Caco2 by RCDII cell line P1 in the presence of 20 μg/mL NKG2D‐blocking mAb or isotype control mAb. (f) CD103 expression on aberrant IEL of RCDII patients and patients with CD on GFD, using flow cytometry analysis. (g) Follow‐up of CD103 expression on aberrant IEL from a representative RCDII patient, showing persistent villous atrophy after first‐line treatment (cladribine; non‐responding) and complete mucosal recovery after second‐line treatment (autologous stem cell transplantation; responding). t = 0 at diagnosis and start treatment, t = 1 is 3 months after first‐line treatment, t = 2 and t = 3 is 3, respectively, 6 months after stem cell transplantation. (h) Histograms of CD103 expression on RCDII cell lines P1 and P2 using flow cytometry analysis; grey shaded peak, isotype‐matched control. Cell experiments were done in triplicate. * P ≤ 0.05, *** P ≤ 0.001, unpaired t ‐test, results shown as mean + sem.

    Journal: Clinical & Translational Immunology

    Article Title: Aberrant intra‐epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103 ‐β7‐receptor‐mediated granzyme‐B degranulation which can be restored by etrolizumab

    doi: 10.1002/cti2.70099

    Figure Lengend Snippet: Aberrant intra‐epithelial T‐lymphocyte (IEL) demonstrate upregulated expression of CD103 and require cell–cell binding to induce enterocyte killing. (a) Refractory celiac disease type II (RCDII) cell‐induced cytotoxicity of Caco2 cells in the presence of a transwell system. Cell death was measured after 16 h of co‐incubation at an effector:target ratio 2:1. (b) Degranulation by RCDII cells in the presence of a transwell system. CD107a expression was measured after 4 h of co‐incubation with Caco2 cells at an effector:target ratio 2:1. (c) NKG2D expression on aberrant IEL of RCDII patients and patients with celiac disease (CD) on gluten‐free diet (GFD), using flow cytometry analysis. Activated CD8+ T cells served as positive control. (d) Representative histograms of NKG2D expression on RCDII cell lines P1 and P2 using flow cytometry; grey shaded peak, isotype‐matched control. (e) Killing of epithelial cells Caco2 by RCDII cell line P1 in the presence of 20 μg/mL NKG2D‐blocking mAb or isotype control mAb. (f) CD103 expression on aberrant IEL of RCDII patients and patients with CD on GFD, using flow cytometry analysis. (g) Follow‐up of CD103 expression on aberrant IEL from a representative RCDII patient, showing persistent villous atrophy after first‐line treatment (cladribine; non‐responding) and complete mucosal recovery after second‐line treatment (autologous stem cell transplantation; responding). t = 0 at diagnosis and start treatment, t = 1 is 3 months after first‐line treatment, t = 2 and t = 3 is 3, respectively, 6 months after stem cell transplantation. (h) Histograms of CD103 expression on RCDII cell lines P1 and P2 using flow cytometry analysis; grey shaded peak, isotype‐matched control. Cell experiments were done in triplicate. * P ≤ 0.05, *** P ≤ 0.001, unpaired t ‐test, results shown as mean + sem.

    Article Snippet: The intestinal epithelial cell line Caco2 was obtained from the American Type Culture Collection (ATCC) and cultured with DMEM medium (BioWhittaker) containing 10% FBS (GE Healthcare Life Sciences) and 100 IU penicillin/100 μg/mL streptomycin (1% P/S) at 37°C.

    Techniques: Expressing, Binding Assay, Incubation, Flow Cytometry, Positive Control, Control, Blocking Assay, Transplantation Assay, Biomarker Discovery

    Aberrant intra‐epithelial T‐lymphocyte (IEL)‐enterocyte binding via CD103 induces granzyme‐B‐mediated enterocyte cell death. (a) Killing of Caco2 epithelial cells by refractory celiac disease type II (RCDII) cell lines in the presence of 10 μg/mL CD103‐blocking mAb or isotype control. Cell death was measured after 16 h of co‐incubation at an effector:target ratio 2:1. (b) Degranulation by RCDII cell lines, measured by CD107a expression, in the presence of 10 μg/mL CD103‐blocking mAb or the matching isotype control. Degranulation was measured after 4 h of co‐incubation with Caco2 cells at an effector:target ratio 2:1. (c) Secretion of granzyme‐B by RCDII cell lines co‐incubated with Caco2 cells in the presence of 10 μg/mL CD103‐blocking mAb compared to the isotype control. Secretion was measured after 6 h of co‐incubation at an effector:target ratio 2:1. (d) Upper left picture: small intestinal organoids; upper right picture: attachment of RCDII cells to an organoid (blue arrow); lower left picture: RCDII cells induce killing of organoids (red arrows); lower right picture: in the presence of 10 μg/mL CD103‐blocking mAb RCDII–induced organoid cell death is evidently reduced, illustrated by the presence of viable organoids (green arrows). (e) Induction of organoid cell death by RCDII cells P2 in the presence of 10 μg/mL CD103‐blocking antibody or an isotype control, measured by cell count via microscopy. Killing was measured after 24 h of co‐incubation at an effector:target ratio 50:1. Figure , upper pictures 25× magnification, lower pictures 10× magnification, using an Olympus microscope. Cell experiments for Figure performed in duplicate, other cell experiments performed in triplicate. *** P ≤ 0.001, unpaired t ‐test, results shown as mean + sem.

    Journal: Clinical & Translational Immunology

    Article Title: Aberrant intra‐epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103 ‐β7‐receptor‐mediated granzyme‐B degranulation which can be restored by etrolizumab

    doi: 10.1002/cti2.70099

    Figure Lengend Snippet: Aberrant intra‐epithelial T‐lymphocyte (IEL)‐enterocyte binding via CD103 induces granzyme‐B‐mediated enterocyte cell death. (a) Killing of Caco2 epithelial cells by refractory celiac disease type II (RCDII) cell lines in the presence of 10 μg/mL CD103‐blocking mAb or isotype control. Cell death was measured after 16 h of co‐incubation at an effector:target ratio 2:1. (b) Degranulation by RCDII cell lines, measured by CD107a expression, in the presence of 10 μg/mL CD103‐blocking mAb or the matching isotype control. Degranulation was measured after 4 h of co‐incubation with Caco2 cells at an effector:target ratio 2:1. (c) Secretion of granzyme‐B by RCDII cell lines co‐incubated with Caco2 cells in the presence of 10 μg/mL CD103‐blocking mAb compared to the isotype control. Secretion was measured after 6 h of co‐incubation at an effector:target ratio 2:1. (d) Upper left picture: small intestinal organoids; upper right picture: attachment of RCDII cells to an organoid (blue arrow); lower left picture: RCDII cells induce killing of organoids (red arrows); lower right picture: in the presence of 10 μg/mL CD103‐blocking mAb RCDII–induced organoid cell death is evidently reduced, illustrated by the presence of viable organoids (green arrows). (e) Induction of organoid cell death by RCDII cells P2 in the presence of 10 μg/mL CD103‐blocking antibody or an isotype control, measured by cell count via microscopy. Killing was measured after 24 h of co‐incubation at an effector:target ratio 50:1. Figure , upper pictures 25× magnification, lower pictures 10× magnification, using an Olympus microscope. Cell experiments for Figure performed in duplicate, other cell experiments performed in triplicate. *** P ≤ 0.001, unpaired t ‐test, results shown as mean + sem.

    Article Snippet: The intestinal epithelial cell line Caco2 was obtained from the American Type Culture Collection (ATCC) and cultured with DMEM medium (BioWhittaker) containing 10% FBS (GE Healthcare Life Sciences) and 100 IU penicillin/100 μg/mL streptomycin (1% P/S) at 37°C.

    Techniques: Binding Assay, Blocking Assay, Control, Incubation, Expressing, Cell Characterization, Microscopy

    Etrolizumab inhibits granzyme‐B secretion and restores enterocyte viability. (a) Histograms of β7 expression on refractory celiac disease type II (RCDII) cell lines P1 and P2; grey shaded peak, isotype‐matched control. (b) Caco2 cell death by RCDII cells in the presence of 50 μg/mL etrolizumab or isotype control. Cell death was determined after 16 h of co‐incubation at an effector:target ratio 2:1. (c) Degranulation by RCDII cell lines in the presence of 50 μg/mL etrolizumab or the matching isotype control. Degranulation was measured after 4 h of co‐incubation with Caco2 cells at an effector:target ratio 2:1. (d) Secretion of granzyme‐B by RCDII cell lines co‐incubated with enterocyte Caco2 cells in the presence of 50 μg/mL etrolizumab compared to the isotype control. Secretion was measured after 6 h of co‐incubation at an effector:target ratio 2:1. (e) Upper picture: RCDII cells attach to the organoid surface and cause membrane disruption (red arrow), inducing organoid cell death; lower picture: the attachment of RCDII cells to organoids and subsequent organoid cell death is decreased in the presence of 50 μg/mL etrolizumab antibody. (f) Induction of organoid cell death by RCDII cells P2 in the presence of 50 μg/mL etrolizumab or an isotype control, measured by cell count via microscopy. Killing was measured after 24 h of co‐incubation at an effector:target ratio 20:1. Figure , pictures 10× magnification, using an Olympus microscope. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results shown as mean + sem.

    Journal: Clinical & Translational Immunology

    Article Title: Aberrant intra‐epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103 ‐β7‐receptor‐mediated granzyme‐B degranulation which can be restored by etrolizumab

    doi: 10.1002/cti2.70099

    Figure Lengend Snippet: Etrolizumab inhibits granzyme‐B secretion and restores enterocyte viability. (a) Histograms of β7 expression on refractory celiac disease type II (RCDII) cell lines P1 and P2; grey shaded peak, isotype‐matched control. (b) Caco2 cell death by RCDII cells in the presence of 50 μg/mL etrolizumab or isotype control. Cell death was determined after 16 h of co‐incubation at an effector:target ratio 2:1. (c) Degranulation by RCDII cell lines in the presence of 50 μg/mL etrolizumab or the matching isotype control. Degranulation was measured after 4 h of co‐incubation with Caco2 cells at an effector:target ratio 2:1. (d) Secretion of granzyme‐B by RCDII cell lines co‐incubated with enterocyte Caco2 cells in the presence of 50 μg/mL etrolizumab compared to the isotype control. Secretion was measured after 6 h of co‐incubation at an effector:target ratio 2:1. (e) Upper picture: RCDII cells attach to the organoid surface and cause membrane disruption (red arrow), inducing organoid cell death; lower picture: the attachment of RCDII cells to organoids and subsequent organoid cell death is decreased in the presence of 50 μg/mL etrolizumab antibody. (f) Induction of organoid cell death by RCDII cells P2 in the presence of 50 μg/mL etrolizumab or an isotype control, measured by cell count via microscopy. Killing was measured after 24 h of co‐incubation at an effector:target ratio 20:1. Figure , pictures 10× magnification, using an Olympus microscope. Cell experiments were done in triplicate. *** P ≤ 0.001, unpaired t ‐test, results shown as mean + sem.

    Article Snippet: The intestinal epithelial cell line Caco2 was obtained from the American Type Culture Collection (ATCC) and cultured with DMEM medium (BioWhittaker) containing 10% FBS (GE Healthcare Life Sciences) and 100 IU penicillin/100 μg/mL streptomycin (1% P/S) at 37°C.

    Techniques: Expressing, Control, Incubation, Membrane, Disruption, Cell Characterization, Microscopy